心臟去心房颤动市场 - 全球产业规模、份额、趋势、机会、预测：按产品、最终用户、地区和竞争对手划分，2021-2031年

全球心臟去心房颤动市场预计将从 2025 年的 105.5 亿美元成长到 2031 年的 144.6 亿美元，复合年增长率为 5.39%。

这些心臟去心房颤动是专门用于向心臟输送治疗性电击的医疗设备，能够有效终止危及生命的心律不整，例如室颤，并恢復正常窦性心律。市场成长的主要驱动力是全球人口老化以及需要紧急治疗的心血管疾病发生率不断上升。此外，政府旨在促进在公共场所广泛使用自动体外心臟去心房颤动（AED）的强制性规定，以及医疗设备的加强，都显着推动了该行业的扩张。

然而，该行业面临着许多挑战，尤其是严格的法规环境和频繁的产品召回，这些都可能延缓产品上市并增加生产成本。这些障碍阻碍了製造商快速回应由沉重疾病负担驱动的全球日益增长的需求。正如欧洲心臟学会2024年报告所述，心血管疾病每年在成员国夺走超过300万人的生命，凸显了可靠治疗性介入的迫切需求。

市场驱动因素

心血管疾病和心律不整的日益普遍是全球心臟去心房颤动颤器市场的主要驱动力。全球心臟麻痹（SCA）的发病率上升，使得治疗设备的需求迫切，为寻求扩大规模以满足临床需求的製造商创造了巨大的商业性机会。这种沉重的疾病负担也促成了主要产业参与者的强劲财务表现。例如，美敦力在其2024年5月发布的「2024财年及第四季财务表现」新闻稿中宣布，其心血管产品组合在该财年创造了118.31亿美元的收入，凸显了这些治疗性介入的重要性。此类事件发生频率的不断增加进一步强调了这种需求。根据猝死基金会于2024年10月发布的「最新统计」报告，心臟麻痹登记系统（CARES）记录了2024年137,119例院外心臟麻痹病例，显示有大量患者需要去心房颤动治疗。

同时，公共场所去心房颤动（PAD）部署的扩大正在改变整个产业。当局正在增加机场、学校等公共场所自动体外心臟去心房颤动（AED）的安装，这一策略得到了临床数据的支持，数据显示其优于延迟响应。根据猝死基金会2024年10月发布的《猝死真相》报告，在配备AED的医疗机构中，心臟麻痹患者的生存率高达93%，而未配备AED的医疗机构中，这一比例仅为9%。这一显着差异正在推动法律支持扩大AED的普及范围和资金筹措，并促进体外去颤器领域的持续销售成长。

市场挑战

严格的法规结构及其带来的合规义务是心臟去心房颤动市场成长的主要障碍。由于这些设备被归类为高风险生命支持技术，因此受到国际卫生机构的严格审查。检验安全性和有效性的复杂核准程序往往导致产品开发週期漫长。製造商被迫投入大量资金和技术资源以满足不断变化的合规标准，这直接增加了生产成本，并限制了可用于研发和创新的资金。因此，先进去心房颤动技术的发布经常被推迟，即使市场需求旺盛，也难以快速进入市场。

这些法规带来的财务和营运压力已反映在近期的行业指标中。 MedTech Europe 的一项 2025 年研究表明，根据新的医疗设备法规 (MDR)，医疗设备的认证和维护成本将比先前的指令增加高达 100%，而选择欧洲作为其首发市场的大型製造商数量将减少 33%。这种法规环境造成了严重的瓶颈，迫使企业推迟甚至在某些情况下从关键市场撤回拯救生命的心臟器械，从而阻碍了该行业应对日益严重的全球心血管疾病负担的能力。

市场趋势

在全球心臟去心房颤动市场，一场向无导线和血管外植入式系统的关键技术变革正在进行，旨在减少传统经静脉导线相关的血管损伤和导线断裂等长期併发症。这一趋势推动了相关设备的商业化，这些设备透过将去心房颤动导线置于胸骨下或皮下，有效地避免了对心臟和静脉的损伤，同时确保了治疗效果。美敦力公司在其2024年9月的新闻稿《美敦力公布EV ICD全球关键性试验最终结果：证实高ATP成功率和有效去心房颤动》中，展示了这一设计演进的成功，其中Aurora EV-ICD系统在终止室性心动过速/室颤发作方面实现了100%的成功率，在终止室性心动过速/室颤发作方面实现了100%的成功率，在起搏过速7%的成功率方面实现了7%。这表明血管外植入可以提供与上一代静脉植入产品相当的可靠治疗。

同时，物联网 (IoT) 连接的融合正在变革体外去心房颤动 ( AED) 产业，独立的硬体设备正演变为智慧化的、网路整合的反应节点。这些智慧 AED 旨在自动执行远端自诊断，以确保随时可用，并将即时位置资讯传输至紧急指挥中心，从而显着缩短心臟疾病停时进行电击去颤的时间。对这种互联生态系统的需求正在推动该领域的巨额投资。例如，Avive Solutions 在 2024 年 4 月发布的题为「Avive Solutions 获得 5,650 万美元成长资金」的新闻稿中宣布，该公司已获得 5,650 万美元的资金，用于加速其在美国部署互联 AED 网络，这凸显了该行业向数据驱动型紧急应变解决方案的转变。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球心臟去心房颤动销售市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类别（植入式心臟整流去颤器(ICD)、体外去心房颤动、穿戴式去心房颤动(WCDS)、高级生命维持设备、其他）
  • 依最终使用者（医院/诊所、门诊中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美心臟去心房颤动销售市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲心臟去心房颤动销售市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区心臟去心房颤动销售市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章 中东和非洲心臟去心房颤动销售市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美心臟去心房颤动市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球心臟去心房颤动销售市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• ST. Jude Medical, Inc.
• Heartsine Technologies, Inc.
• Zoll Medical Corporation
• Medical Research Laboratories, Inc.
• Sorin Group
• Boston Scientific Corporation
• Physio-Control, Inc.
• Laerdal Medical Corporation
• Cardiac Science Corporation
• Medtronic Physio-Control Corporation
• Koninklijke Philips NV
• Nihon Kohden Corporation
• Cardiac Science, Inc.
• Stryker Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Cardiology Defibrillators Devices Sales Market is projected to expand from USD 10.55 Billion in 2025 to USD 14.46 Billion by 2031, registering a CAGR of 5.39%. These cardiology defibrillators are specialized medical devices designed to administer therapeutic electrical shocks to the heart, effectively halting life-threatening arrhythmias like ventricular fibrillation and reestablishing a normal sinus rhythm. The market's growth is largely fueled by an aging global population and the increasing incidence of cardiovascular conditions requiring urgent treatment. Furthermore, government mandates aimed at boosting the availability of automated external defibrillators in public areas, combined with enhancements in healthcare infrastructure, are providing significant support for the sector's expansion.

However, the industry encounters notable difficulties, particularly regarding strict regulatory environments and frequent product recalls that can postpone market access and increase production expenses. These hurdles impede manufacturers' capacity to quickly satisfy the rising global demand resulting from the substantial disease burden. As reported by the European Society of Cardiology in 2024, cardiovascular disease claimed over 3 million lives annually across its member nations, emphasizing the critical need for dependable therapeutic interventions.

Market Driver

The increasing prevalence of cardiovascular diseases and arrhythmias acts as the main driver for the Global Cardiology Defibrillators Devices Sales Market. As the global incidence of sudden cardiac arrest (SCA) rises, there is an urgent need for therapeutic devices, generating significant commercial activity for manufacturers expanding to meet clinical demands. This high disease burden results in strong financial performance for major industry players; for instance, Medtronic reported in its 'Medtronic Reports Full Year and Fourth Quarter Fiscal 2024 Financial Results' press release in May 2024 that its Cardiovascular Portfolio achieved $11.831 billion in revenue for the fiscal year, highlighting the vital nature of these interventions. The frequency of these events reinforces this necessity; the Sudden Cardiac Arrest Foundation noted in its 'Latest Statistics' report in October 2024 that 137,119 out-of-hospital cardiac arrest incidents were recorded by the Cardiac Arrest Registry to Enhance Survival (CARES) in 2024, indicating a vast patient population requiring potential defibrillation therapy.

Concurrently, the growth of Public Access Defibrillator (PAD) initiatives is transforming the sector. Authorities are increasingly installing automated external defibrillators (AEDs) in public locations such as airports and schools, a strategy supported by clinical data proving their superiority over delayed responses. According to the Sudden Cardiac Arrest Foundation's 'Sudden Cardiac Arrest Facts' report from October 2024, cardiac arrest victims in facilities equipped with an AED have a 93% chance of survival compared to just 9% when no device is present. This significant contrast drives legislative backing for broader accessibility and funding, thereby promoting consistent sales growth within the external device segment.

Market Challenge

Rigorous regulatory frameworks and the associated compliance obligations constitute a major obstacle to the growth of the cardiology defibrillators market. Because these devices are categorized as high-risk, life-sustaining technologies, they undergo intense scrutiny from international health authorities. The intricate approval procedures needed to verify safety and effectiveness often lead to prolonged product development cycles. Manufacturers are forced to allocate significant financial and technical resources to satisfy these evolving compliance standards, which directly increases production costs and limits the funds available for research and innovation. Consequently, the release of advanced defibrillation technologies is frequently stalled, preventing rapid market entry even when demand is high.

The financial and operational pressure resulting from these regulations is reflected in recent industry metrics. A 2025 survey by MedTech Europe indicated that certification and maintenance expenses for medical devices under the new Medical Device Regulation (MDR) have risen by as much as 100% relative to earlier directives, leading to a 33% drop in large manufacturers selecting Europe as their initial launch region. This regulatory environment creates a significant bottleneck, compelling companies to delay or potentially withdraw life-saving cardiac devices from key markets, thereby hampering the industry's ability to address the growing global burden of cardiovascular disease.

Market Trends

The Global Cardiology Defibrillators Devices Sales Market is experiencing a decisive technological shift toward leadless and extravascular implantable systems aimed at reducing long-term complications linked to traditional transvenous leads, such as vascular injury and lead fractures. This trend involves the commercialization of devices where defibrillation leads are placed substernally or subcutaneously, effectively avoiding the heart and veins while ensuring therapeutic potency. Demonstrating the success of this design evolution, Medtronic announced in a September 2024 press release titled 'Medtronic EV ICD global pivotal trial final results demonstrate high ATP success and effective defibrillation' that the Aurora EV-ICD system attained a 100% success rate for terminating ventricular tachycardia/ventricular fibrillation episodes via shocks and a 77% success rate for anti-tachycardia pacing, proving that extravascular configurations can deliver reliable therapy comparable to transvenous predecessors.

Simultaneously, the external defibrillator segment is being reshaped by the integration of Internet of Things (IoT) connectivity, turning standalone hardware into intelligent, network-integrated response nodes. These smart AEDs are designed to automatically perform remote self-diagnostics to ensure operational readiness and transmit real-time location data to emergency dispatchers, drastically shortening the critical time-to-shock window during cardiac events. The demand for such connected ecosystems is driving substantial investment capital into the sector; for example, Avive Solutions revealed in an April 2024 press release titled 'Avive Solutions Raises $56.5M in Growth Funding' that the company secured $56.5 million to accelerate the deployment of its connected AED network across the United States, underscoring the industry's pivot toward data-driven emergency response solutions.

Key Market Players

• ST. Jude Medical, Inc.
• Heartsine Technologies, Inc.
• Zoll Medical Corporation
• Medical Research Laboratories, Inc.
• Sorin Group
• Boston Scientific Corporation
• Physio-Control, Inc.
• Laerdal Medical Corporation
• Cardiac Science Corporation
• Medtronic Physio-Control Corporation
• Koninklijke Philips N.V.
• Nihon Kohden Corporation
• Cardiac Science, Inc.
• Stryker Corporation

Report Scope

In this report, the Global Cardiology Defibrillators Devices Sales Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiology Defibrillators Devices Sales Market, By Product

• Implantable Cardioverter Defibrillator (ICDs)
• External Defibrillator
• Wearable Cardioverter Defibrillator (WCDS)
• Advanced Life Support Units
• Others

Cardiology Defibrillators Devices Sales Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Cardiology Defibrillators Devices Sales Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiology Defibrillators Devices Sales Market.

Available Customizations:

Global Cardiology Defibrillators Devices Sales Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiology Defibrillators Devices Sales Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Implantable Cardioverter Defibrillator (ICDs), External Defibrillator, Wearable Cardioverter Defibrillator (WCDS), Advanced Life Support Units, Others)
  • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Cardiology Defibrillators Devices Sales Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User

7. Europe Cardiology Defibrillators Devices Sales Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. France Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End User

8. Asia Pacific Cardiology Defibrillators Devices Sales Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. India Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End User

9. Middle East & Africa Cardiology Defibrillators Devices Sales Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. UAE Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. South Africa Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. South America Cardiology Defibrillators Devices Sales Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cardiology Defibrillators Devices Sales Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End User
  • 10.3.2. Colombia Cardiology Defibrillators Devices Sales Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End User
  • 10.3.3. Argentina Cardiology Defibrillators Devices Sales Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cardiology Defibrillators Devices Sales Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. ST. Jude Medical, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Heartsine Technologies, Inc.
• 15.3. Zoll Medical Corporation
• 15.4. Medical Research Laboratories, Inc.
• 15.5. Sorin Group
• 15.6. Boston Scientific Corporation
• 15.7. Physio-Control, Inc.
• 15.8. Laerdal Medical Corporation
• 15.9. Cardiac Science Corporation
• 15.10. Medtronic Physio-Control Corporation
• 15.11. Koninklijke Philips N.V.
• 15.12. Nihon Kohden Corporation
• 15.13. Cardiac Science, Inc.
• 15.14. Stryker Corporation

16. Strategic Recommendations

17. About Us & Disclaimer